secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sensus Healthcare, Inc. (SRTS)
CIK:        0001494891
Form:       8-K
Filed at:   2021-08-05T23:59:59+00:00
Accession:  0001213900-21-040518
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sensus Healthcare Q2 revenue up 358% YoY to $5.4M; net loss narrows to $0.3M
----------------------------------------------------------------------------

- Revenue $5.4M, up 358% YoY and 77% sequentially; shipped 17 systems including 7 SRT-100 Vision.
- Net loss improved to $(0.3)M ($0.02 loss per share) from $(2.6)M loss in Q2 2020; Adjusted EBITDA $(0.1)M vs $(2.3)M.
- Cash $15.2M at June 30, 2021; worldwide installed base of SRT systems reached 515.
- CMS increased reimbursement for SRT effective Jan 2021; new leasing options; expanding international in China and India.
- Management cautiously optimistic for sequential growth; on track to profitability.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1494891/000121390021040518/0001213900-21-040518-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1494891/000121390021040518/ea145134-8k_sensushealth.htm
  HTML page:      https://secwatch.observer/filing/0001213900-21-040518

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer